OnKure Therapeutics, Inc. OKUR Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from OnKure Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s cash ratio?
- OnKure Therapeutics, Inc. (OKUR) reported cash ratio of 13.4× in Q1 2026.
- How has OnKure Therapeutics, Inc.'s cash ratio changed year-over-year?
- OnKure Therapeutics, Inc.'s cash ratio increased by 21.8% year-over-year, from 11× to 13.4×.
- What is the long-term trend for OnKure Therapeutics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s cash ratio has grown at a -3.2% compound annual growth rate (CAGR), from 11.7× to 10×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.